Troclose

Israel-based medical portfolio company of The Trendlines Group, Gordian Surgical, has commenced the first human clinical trial of its TroClose1200 for laparoscopic surgery.

The TroClose1200 is an innovative trocar featuring an integrated closure mechanism which is used to open the abdomen to insert optical tools and other surgical equipment prior to surgery where the integrated closure mechanism also allows the closure of the incision.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The equipment is designed to improve safety while ensuring convenience and efficacy during the surgery.

Its release mechanism allows the insertion of sutures into the tissue at the beginning of the procedure, instead of inserting it at the end hence saving time involved in the procedure.

The sutures remains intact in one place throughout the operation and incisions are closed almost automatically after the TroClose1200 is removed.

Gordian Surgical medical director and Poriya Medical Center, Israel director of surgery Dr Nissim Geron said: “The innovative device functioned very well and allowed for closure of incisions that would have been very difficult to perform without the use of Gordian’s product.

“The device demonstrated excellent performance and would be a great asset for any bariatric surgery, most especially on morbidly obese patients.”

“The product is safe, user-friendly and represents an important breakthrough in laparoscopic surgery.”

So far, the company had undertaken 13 successful procedures in Israel and India.

India-base laparoscopic surgeon, Dr Surendra Ugale said: “I am extremely satisfied with the TroClose1200.

“The device demonstrated excellent performance and would be a great asset for any bariatric surgery, most especially on morbidly obese patients.”

Image: Gordian Surgical’s TroClose1200. Photo: courtesy of PR Newswire Association LLC.